Titlebook: History of Nordic Computing; IFIP WG9.7 First Wor Janis Bubenko,John Impagliazzo,Arne Sølvberg Conference proceedings 2005 IFIP Internation

Nonconformist

Christian Gram,Tero Laaksonen,Tomas Ohlin,Harold Lawson,Rolf Skår,Ole Stangegaardonal risk factor screening, is a high level of genetically determined Lp(a) lipoprotein. It should be analyzed in any diagnostic work-up in cases of CHD occurring prior to the age of 60–65 as well as in any risk factor screening of populations..There is abundant evidence that specific genetic and en

ESO

Harold Lawson pathological anatomy, bio­ chemical and clinical diagnosis, diet, pharmacological and non-pharmacological ther­ apy. The numerous contributions made by authors in the field of epidemiology and the prevention of atherosclerosis were also fundamental since not only research centres but also doctors a

detach

社团

Lauri Fontellof the negative trials poses problems only recently delt with in the literature. Issues of the sampling frame, exclusions, subjects eligible but not randomized, subgroup results, etc. and their influence on inference will be discussed, with the aim to redress the balance between randomised trials an

Osmosis

1868-4238 omputers. In many cases, however, companies and institutions did not further develop or exploit Nordic computing hardware, even though it exhibited technical advantages. Consequently, in the 1970s, US computers978-1-4614-9889-6978-0-387-24168-5Series ISSN 1868-4238 Series E-ISSN 1868-422X

Ceramic

Conference proceedings 2005computer in Finland, as well as the computers of Norsk Data in Norway followed the early computers. In many cases, however, companies and institutions did not further develop or exploit Nordic computing hardware, even though it exhibited technical advantages. Consequently, in the 1970s, US computers

凹处

Reino Kurki-Suoniothis concept. It therefore represents a timely and valuable resource for internal medicine, cardiology, angiology cardiovascular surgeons, pathology clinicians, researchers, trainees, and students..978-3-030-20247-7978-3-030-20245-3

humectant

Relinquish

thoxy)androst-5-en-17-one HCl. U-18666A blocks biosynthesis of cholesterol (C) by inhibiting conversion from D to C. Diets containing C (2%), the bile acid sequestrant colestipol HCl (1%), clofibrate (0.2%), combination of colestipol HCl and clofibrate, or basal diet were fed to normal or U-18666A (

喃喃而言

Börje Langeforsium against disease to either prevent or reverse this insidious killer and debilitant of human lives. Because of this void the First Brook Lodge Symposium on Anti­ Atherosclerosis Drug Discovery was convened at Brook Lodge in Augusta, Michigan, August 13-15, 1975. The symposium was sponsored by The